CRBU · Caribou Biosciences, Inc.
$1.65
+0.03 (+1.85%)
At close · Jul 21
Market Cap
$164.14M
Shares
99.18M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-18 | 2026-06-17 | |
| 8-K | 2026-06-11 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-24 | 2025-12-31 | |
| 8-K | 2026-03-31 | — | |
| 10-K | 2026-03-05 | 2025-12-31 | |
| 8-K | 2026-03-05 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-11-12 | — | |
| 8-K | 2025-11-03 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-08-12 | — | |
| 8-K | 2025-06-23 | 2025-06-18 | |
| 8-K | 2025-06-13 | 2025-06-12 | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-08 | — | |
| DEF 14A | 2025-04-25 | 2024-12-31 | |
| 8-K | 2025-04-24 | — | |
| 8-K | 2025-03-10 | — | |
| 10-K | 2025-03-10 | 2024-12-31 | |
| 8-K | 2025-01-13 | 2025-01-12 | |
| 8-K | 2025-01-02 | — | |
| 10-Q | 2024-11-06 | 2024-09-30 | |
| 8-K | 2024-11-06 | — | |
| 8-K/A | 2024-09-27 | 2024-09-01 | |
| 8-K | 2024-09-03 | 2024-09-01 | |
| 8-K | 2024-08-12 | — | |
| 10-Q | 2024-08-06 | 2024-06-30 | |
| 8-K | 2024-08-06 | — | |
| 8-K | 2024-07-16 | — | |
| 8-K | 2024-06-14 | 2024-06-13 | |
| 8-K | 2024-06-03 | 2024-06-02 | |
| 8-K | 2024-05-07 | — | |
| 10-Q | 2024-05-07 | 2024-03-31 | |
| DEF 14A | 2024-04-25 | 2023-12-31 | |
| 8-K | 2024-04-04 | — | |
| 10-K | 2024-03-11 | 2023-12-31 | |
| 8-K | 2024-03-11 | — | |
| 8-K | 2024-01-08 | 2024-01-07 | |
| 8-K | 2023-12-22 | — | |
| 8-K | 2023-12-12 | 2023-12-11 | |
| 10-Q/A | 2023-11-17 | 2023-03-31 | |
| 10-Q/A | 2023-11-17 | 2023-06-30 | |
| 10-Q | 2023-11-07 | 2023-09-30 | |
| 8-K | 2023-11-07 | — | |
| 8-K | 2023-10-18 | — | |
| 8-K | 2023-09-26 | — | |
| 10-Q | 2023-08-08 | 2023-06-30 |
Showing 1–50 of 101 filings
Key facts
CIK
1619856
CUSIP
142038108
13F (30d)
12 filings
10 filers
Visit website
Investor relations